Targetable NOTCH1 rearrangements in reninoma

Nat Commun. 2023 Sep 25;14(1):5826. doi: 10.1038/s41467-023-41118-8.

Abstract

Reninomas are exceedingly rare renin-secreting kidney tumours that derive from juxtaglomerular cells, specialised smooth muscle cells that reside at the vascular inlet of glomeruli. They are the central component of the juxtaglomerular apparatus which controls systemic blood pressure through the secretion of renin. We assess somatic changes in reninoma and find structural variants that generate canonical activating rearrangements of, NOTCH1 whilst removing its negative regulator, NRARP. Accordingly, in single reninoma nuclei we observe excessive renin and NOTCH1 signalling mRNAs, with a concomitant non-excess of NRARP expression. Re-analysis of previously published reninoma bulk transcriptomes further corroborates our observation of dysregulated Notch pathway signalling in reninoma. Our findings reveal NOTCH1 rearrangements in reninoma, therapeutically targetable through existing NOTCH1 inhibitors, and indicate that unscheduled Notch signalling may be a disease-defining feature of reninoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Juxtaglomerular Apparatus / metabolism
  • Juxtaglomerular Apparatus / pathology
  • Kidney Glomerulus / pathology
  • Kidney Neoplasms* / metabolism
  • Receptor, Notch1 / genetics
  • Renin* / metabolism
  • Signal Transduction / genetics

Substances

  • Renin
  • NOTCH1 protein, human
  • Receptor, Notch1